Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Lanlin Shen"'
Autor:
Gang Shi, Pengyi Shi, Yan Yu, Jia Xu, Jinhu Ma, Yong Zhang, Zhexu Dong, Lanlin Shen, Lei Dai, Lin Cheng, Ping Cheng, Hongxin Deng
Publikováno v:
Molecular Therapy: Oncolytics, Vol 23, Iss , Pp 488-500 (2021)
Malignant ascites frequently occur in patients with advanced ovarian cancer at initial diagnosis, and in almost all cases of relapse, they are closely related to poor prognosis, chemoresistance, and metastasis. To date, effective management strategie
Externí odkaz:
https://doaj.org/article/b13fbf4f68bb42d88d66d339a8f15964
Autor:
Yuan Zhang, Xiang Gao, Jingyan Yi, Xiaolin Sang, Zhihong Dai, Zhiwei Tao, Min Wang, Lanlin Shen, Yaxun Jia, Daqing Xie, Hailing Cheng, Zhiyu Liu, Pixu Liu
Publikováno v:
Cell Death and Disease, Vol 12, Iss 1, Pp 1-15 (2021)
Abstract High levels of Basic Transcription Factor 3 (BTF3) have been associated with prostate cancer. However, the mechanisms underlying the role of BTF3 as an oncogenic transcription factor in prostate tumorigenesis have not been explored. Herein,
Externí odkaz:
https://doaj.org/article/294c0a2da88b424ead105cfe881aca98
Autor:
Jingyan Yi, Chongya Liu, Zhiwei Tao, Min Wang, Yaxun Jia, Xiaolin Sang, Lanlin Shen, Yijue Xue, Kui Jiang, Fuwen Luo, Pixu Liu, Hailing Cheng
Publikováno v:
EBioMedicine, Vol 43, Iss , Pp 225-237 (2019)
Background: While PARP inhibitors and CDK4/6 inhibitors, the two classes of FDA-approved agents, have shown promising clinical benefits, there is an urgent need to develop new therapeutic strategies to improve clinical response. Meanwhile, extending
Externí odkaz:
https://doaj.org/article/f53d36afe16b4bcb8a9eaaa5adf3f8dc
Autor:
Min Wang, Yijue Xue, Lanlin Shen, Pan Qin, Xiaolin Sang, Zhiwei Tao, Jingyan Yi, Jia Wang, Pixu Liu, Hailing Cheng
Publikováno v:
Redox Biology, Vol 24, Iss , Pp - (2019)
Cervical cancer has poor prognosis and patients are often diagnosed at advanced stages of the disease with limited treatment options. There is thus an urgent need for the discovery of new therapeutic strategies in cervical cancer. The activation of S
Externí odkaz:
https://doaj.org/article/e107407b6ac34ff69b8bfcccacf130b7
Autor:
Shuang Chen, Jing Luo, Lanlin Shen, Xuan Liu, Wenshuang Wang, Jia Xu, Yushuang Ren, Yixin Ye, Gang Shi, Fuyi Cheng, Lin Cheng, Xiaolan Su, Lei Dai, Maling Gou, Hongxin Deng
Publikováno v:
ACS Applied Materials & Interfaces. 14:23139-23151
Transplantation of encapsulated islets has been shown to hold a promising potential treatment for type 1 diabetes (T1D). However, there are several obstacles to overcome, such as immune rejection by the host of the grafts, sustainability of islet fun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::024101c276aa51e1eb25e8bc06411fd4
https://doi.org/10.1021/acsami.2c02487
https://doi.org/10.1021/acsami.2c02487
Autor:
Jia Xu, Zhexu Dong, Lanlin Shen, Lei Dai, Hongxin Deng, Jinhu Ma, Lin Cheng, Gang Shi, Ping Cheng, Pengyi Shi, Zhang Yong, Yan Yu
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 23, Iss, Pp 488-500 (2021)
Molecular Therapy: Oncolytics, Vol 23, Iss, Pp 488-500 (2021)
Malignant ascites frequently occur in patients with advanced ovarian cancer at initial diagnosis, and in almost all cases of relapse, they are closely related to poor prognosis, chemoresistance, and metastasis. To date, effective management strategie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cf8a8b9c83b668d2d826779126db024
https://doi.org/10.1016/j.omto.2021.11.008
https://doi.org/10.1016/j.omto.2021.11.008
Autor:
Hailing Cheng, Yijue Xue, Fuwen Luo, Kui Jiang, Pixu Liu, Lanlin Shen, Yaxun Jia, Xiaolin Sang, Chongya Liu, Zhiwei Tao, Min Wang, Jingyan Yi
Publikováno v:
EBioMedicine. 43:225-237
Background While PARP inhibitors and CDK4/6 inhibitors, the two classes of FDA-approved agents, have shown promising clinical benefits, there is an urgent need to develop new therapeutic strategies to improve clinical response. Meanwhile, extending t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8547559b3239d3729c450595afafd354
https://doi.org/10.1016/j.ebiom.2019.03.027
https://doi.org/10.1016/j.ebiom.2019.03.027
Autor:
Wenzhi Zhao, Yuan Zhang, Hailing Cheng, Pixu Liu, Xiaolin Sang, Fuwen Luo, Chongya Liu, Lanlin Shen, Nan Zhang, Xiaonan Wang, Zundong Liu, Yijue Xue, Jinlei Ding, Min Wang, Jingyan Yi
Publikováno v:
Cancer Letters. :54-63
Selective phosphatidylinositol 3 kinase (PI3K) inhibitors are being actively tested in clinical trials for ERα-positive (ER+) breast cancer due to the presence of activating PIK3CA mutations. However, recent studies have revealed that increased ERα
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c2dc4e7f90545f91c6c1c96d36ec57c
https://doi.org/10.1016/j.canlet.2018.09.030
https://doi.org/10.1016/j.canlet.2018.09.030
Autor:
Pixu Liu, Hailing Cheng, Yaxun Jia, Zhiyu Liu, Lanlin Shen, Xiaolin Sang, Yuan Zhang, Xiang Gao, Min Wang, Jingyan Yi, Daqing Xie, Zhiwei Tao, Zhihong Dai
Publikováno v:
Cell Death and Disease, Vol 12, Iss 1, Pp 1-15 (2021)
Cell Death & Disease
Cell Death & Disease
High levels of Basic Transcription Factor 3 (BTF3) have been associated with prostate cancer. However, the mechanisms underlying the role of BTF3 as an oncogenic transcription factor in prostate tumorigenesis have not been explored. Herein, we report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaf5fb25b9ebf68a3886e526d0efe55b
https://doi.org/10.1038/s41419-020-03348-2
https://doi.org/10.1038/s41419-020-03348-2
Autor:
Zhen Xiao, Pixu Liu, Yijue Xue, Hong Shi, Yingying He, Chongya Liu, Lin Xiang, Tingting Shen, Lanlin Shen, Min Wang, Jingyan Yi
Publikováno v:
Oncology Reports
Uterine serous carcinoma (USC) is a subtype of endometrial cancer. Compared with endometrial endometroid carcinoma, the majority of USC cases are more aggressive. Cyclin-dependent kinase inhibitor 2A (P16INK4A) is a canonical tumor suppressor that bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1326b3c605b44d35e3ba33f1a08a3134
https://pubmed.ncbi.nlm.nih.gov/30896884
https://pubmed.ncbi.nlm.nih.gov/30896884